Ardenermin-I-131

N/A

Report date: 2024/12/02 11:05:58

Base Information

Drug NameArdenermin-I-131
Drug Alias NameIodine-131 BLySIodine-131 labeled B-Lymphocyte StimulatorLymphoRad-131LR-131
ClassificationRadiation-emitting productsBiologics
Mechanisms of ActionB cells stimulants
TargetsUpdating
Therapy Area/IndicationsMultiple MyelomaLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHuman Genome Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHuman Genome Sciences Inc
Active IndicationsN/A
Inactive IndicationsMultiple MyelomaLymphoma, Non-Hodgkin

Other Information

ATC CodeN/A
Related LinksN/A